Psoriasis is caused by an immune system malfunction that forces skin cells to grow roughly five times faster than normal. In healthy skin, cells take about 52 days to mature, rise to the surface, and shed. In psoriatic skin, that entire cycle compresses to under 10 days. The result is a pileup of immature cells that forms the thick, scaly, inflamed patches the condition is known for. But the rapid skin turnover is a downstream effect. The true root cause lies in a chain of events that starts with your genes, gets activated by environmental triggers, and plays out through a misfiring immune response.
The Immune System Drives the Disease
Psoriasis is classified as a T-cell-mediated immune disease. T cells are white blood cells that normally defend against infections, but in psoriasis they activate without a real threat and attack healthy skin tissue. Two types of T cells dominate: Th1 and Th17. Together, they flood the skin with inflammatory signaling molecules that tell skin cells (keratinocytes) to multiply at an abnormal rate.
The signaling molecule IL-17A sits at the center of this process. It’s released not only by Th17 cells but also by natural killer cells, mast cells, neutrophils, and other immune cells. Another molecule, interferon-gamma, amplifies the damage by priming other immune cells to produce even more inflammatory signals. This creates a self-reinforcing loop: inflammation triggers more immune activation, which triggers more inflammation, which drives more skin cell production. The cycle doesn’t resolve on its own because the immune system never receives a signal to stand down.
Biopsies of psoriatic skin show characteristic clusters of activated immune cells deep in the skin layers, with CD8+ T cells concentrated specifically in the outermost layer, the epidermis, where the visible damage occurs.
Genetics Load the Gun
You can’t develop psoriasis without a genetic predisposition. More than 80 genetic regions have been linked to the disease, but the strongest single risk factor is a gene variant called HLA-C*06:02. This variant belongs to a group of genes that control how the immune system identifies threats. When this gene variant is present, the immune system is more prone to misidentifying skin cells as targets.
Having the gene variant doesn’t guarantee you’ll develop psoriasis. Many carriers never do. But genetics explain why psoriasis runs in families and why certain populations have higher rates than others. Global prevalence sits at about 4.4%, though it varies significantly by region and ethnicity.
Environmental Triggers Pull the Trigger
Genes create vulnerability. Something in the environment activates it. The most well-documented triggers include:
- Stress: acts as both an initiator of first flares and a booster of existing lesions
- Infections: strep throat is a classic trigger, particularly for the first episode in children and young adults
- Certain medications: some drugs can initiate, trigger, or worsen psoriasis, though separating the effect of the medication from the illness it treats can be difficult
- Alcohol and smoking: alcohol and its metabolites can directly trigger skin lesions, while smoking increases systemic inflammation
- Obesity: excess body fat produces its own inflammatory signals that compound immune dysfunction
These triggers don’t cause psoriasis in people without the genetic predisposition. They activate a disease process that was already primed to happen.
Skin Injury Can Spark New Lesions
A phenomenon specific to psoriasis, called the Koebner response, helps illustrate how sensitive the skin becomes once the disease is active. Any physical injury to healthy-looking skin, whether a cut, scrape, sunburn, or even a tattoo, can trigger new psoriatic plaques at the exact site of the injury. The disruption of the skin’s protective barrier sets off a local immune reaction involving mast cells, which release inflammatory molecules like IL-17 and IL-6. These are the same signals already driving psoriasis elsewhere on the body, so the injured site essentially gets recruited into the disease.
Epigenetics: How Environment Rewires Gene Expression
Between genetics and environment sits a layer called epigenetics, which refers to changes in how genes are read without altering the DNA itself. Environmental exposures like chronic stress, smoking, or obesity can modify chemical tags on your DNA (a process called methylation), dialing certain immune genes up or down. In psoriasis, these modifications increase the expression of inflammatory genes.
One encouraging finding: these changes appear to be partially reversible. Research has shown that methylation patterns in psoriatic skin shift back toward normal levels after just one month of effective treatment targeting the inflammatory protein TNF-alpha. This suggests the epigenetic component isn’t permanently locked in.
The Gut Connection
Emerging evidence links gut health to psoriasis severity. Randomized controlled trials have found that imbalances in gut bacteria contribute to the inflammatory molecules that drive psoriasis. People with psoriasis consistently show an altered ratio of the two dominant bacterial groups in the gut: higher levels of Firmicutes and lower levels of Bacteroidetes compared to healthy individuals. They also tend to have reduced populations of beneficial bacteria like Akkermansia and Prevotella.
When gut bacterial balance is disrupted, the intestinal lining becomes more permeable. Bacterial fragments and their byproducts leak into the bloodstream, triggering immune activation far from the gut itself, including in the skin. Flares of psoriasis have been linked to shifts in microbiome diversity and the emergence of opportunistic pathogens. The elevated Firmicutes-to-Bacteroidetes ratio seen in psoriasis patients has also been tied to a Western diet and obesity, which creates another feedback loop between lifestyle factors and disease activity.
Vitamin D’s Protective Role
Vitamin D plays a direct role in regulating the two processes that go wrong in psoriasis: skin cell growth and immune function. In adequate amounts, it slows keratinocyte proliferation, promotes normal skin cell maturation, and helps maintain the skin’s protective barrier by stimulating the production of ceramides and structural proteins. When vitamin D is deficient or its receptor is dysfunctional, the outermost skin layer fails to differentiate properly, and the basal layer (where new skin cells are born) begins to overproduce.
On the immune side, vitamin D acts as a broad immunomodulator. It inhibits the proliferation of T lymphocytes, the very cells driving psoriasis, and promotes the generation of regulatory T cells that suppress inappropriate immune responses. This dual role in both skin biology and immune regulation explains why vitamin D-based topical treatments have been a mainstay in psoriasis management for decades.
Psoriasis Is a Systemic Disease
Because the underlying problem is immune dysfunction rather than a skin defect, psoriasis affects far more than the skin. The same inflammatory signals circulating through the body increase the risk of other conditions. People with psoriasis are up to 50% more likely to develop cardiovascular disease, with the risk climbing higher in those with more severe skin involvement. Psoriatic arthritis, metabolic syndrome, type 2 diabetes, and depression are also significantly more common.
This systemic nature reinforces that psoriasis is not a surface-level problem. The plaques on the skin are the most visible sign of an immune system that has shifted into a chronic inflammatory state, one that began with inherited genetic variants, was switched on by environmental factors, and sustains itself through interconnected loops of immune signaling, gut dysfunction, and epigenetic change.